Westchester Capital Management, LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 67 filers reported holding BIOPLUS ACQUISITION CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Westchester Capital Management, LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$15,053,701
+1.7%
1,390,0000.0%0.44%
-5.6%
Q2 2023$14,803,501
+8.5%
1,390,000
+6.4%
0.46%
+12.6%
Q1 2023$13,640,841
+707.9%
1,306,594
+695.5%
0.41%
+797.8%
Q4 2022$1,688,418164,2430.05%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders